FDA: Philips CPAP Corrections Weren’t Reported; 222,000 Complaints Were Received

(November 16, 2021, 1:27 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Nov. 12 released a recent inspection report of CPAP maker Philips Respironics Inc.’s manufacturing plant following a recall of 15 million...
To view the full article, register now.